Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.

Kozelsky TF, Meyers GE, Sloan JA, Shanahan TG, Dick SJ, Moore RL, Engeler GP, Frank AR, McKone TK, Urias RE, Pilepich MV, Novotny PJ, Martenson JA; North Central Cancer Treatment Group..

J Clin Oncol. 2003 May 1;21(9):1669-74.

PMID:
12721240
2.

[Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation].

Valls A, Pestchen I, Prats C, Pera J, Aragón G, Vidarte M, Algara M.

Med Clin (Barc). 1999 Nov 27;113(18):681-4. Spanish.

PMID:
10650568
4.

Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial.

Martenson JA Jr, Hyland G, Moertel CG, Mailliard JA, O'Fallon JR, Collins RT, Morton RF, Tewfik HH, Moore RL, Frank AR, Urias RE, Deming RL.

Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):299-303.

PMID:
8635937
5.

Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial.

Giralt J, Regadera JP, Verges R, Romero J, de la Fuente I, Biete A, Villoria J, Cobo JM, Guarner F.

Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1213-9. doi: 10.1016/j.ijrobp.2007.11.009.

PMID:
18243569
6.

Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients.

Jahraus CD, Bettenhausen D, Malik U, Sellitti M, St Clair WH.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1483-7.

PMID:
16099600
7.

The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study.

Yavuz MN, Yavuz AA, Aydin F, Can G, Kavgaci H.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):195-202.

PMID:
12182992
8.

Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial.

Daniele B, Perrone F, Gallo C, Pignata S, De Martino S, De Vivo R, Barletta E, Tambaro R, Abbiati R, D'Agostino L.

Gut. 2001 Jan;48(1):28-33.

9.

[Prevention of radiation-induced diarrhea by smectite. Results of a double-blind randomized, placebo-controlled multicenter study].

Hombrink J, Fröhlich D, Glatzel M, Krauss A, Thiel HJ, Meier J, Hamann D, Mücke R, Glaser FH, Köst S.

Strahlenther Onkol. 2000 Apr;176(4):173-9. German.

PMID:
10812390
10.

Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.

Witzig TE, Silberstein PT, Loprinzi CL, Sloan JA, Novotny PJ, Mailliard JA, Rowland KM, Alberts SR, Krook JE, Levitt R, Morton RF.

J Clin Oncol. 2005 Apr 20;23(12):2606-17.

PMID:
15452187
11.

A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer.

Warde P, O'Sullivan B, Aslanidis J, Kroll B, Lockwood G, Waldron J, Payne D, Bayley A, Ringash J, Kim J, Liu FF, Maxymiw W, Sprague S, Cummings BJ.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):9-13.

PMID:
12182969
12.

Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy.

Gothard L, Cornes P, Brooker S, Earl J, Glees J, Hall E, Peckitt C, Tait D, Yarnold J.

Radiother Oncol. 2005 Jun;75(3):334-41.

PMID:
16086914
13.

Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer.

Gothard L, Cornes P, Earl J, Hall E, MacLaren J, Mortimer P, Peacock J, Peckitt C, Woods M, Yarnold J.

Radiother Oncol. 2004 Nov;73(2):133-9.

PMID:
15542159
14.
15.

The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial.

Kneebone A, Mameghan H, Bolin T, Berry M, Turner S, Kearsley J, Graham P, Fisher R, Delaney G.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):628-35.

PMID:
11597802
16.

A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis.

Baughan CA, Canney PA, Buchanan RB, Pickering RM.

Clin Oncol (R Coll Radiol). 1993;5(1):19-24.

PMID:
8424910
17.

Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients.

Chitapanarux I, Chitapanarux T, Traisathit P, Kudumpee S, Tharavichitkul E, Lorvidhaya V.

Radiat Oncol. 2010 May 5;5:31. doi: 10.1186/1748-717X-5-31.

18.

High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.

Firat S, Murray K, Erickson B.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):201-7.

PMID:
12909234
19.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
20.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM)..

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39.

PMID:
16414206
Items per page

Supplemental Content

Support Center